Categories Multiple Myeloma

Multiple Myeloma | Mr. Kanhaiyalal Gupta | Dr. Ganesh Jaishetwar | Yashoda Hospitals

Multiple Myeloma | Mr. Kanhaiyalal Gupta | Dr. Ganesh Jaishetwar | Yashoda Hospitals I was diagnosed with bone cancer and underwent stem cell transplant under I am so healthy today that it feels like a rebirth. To all those with this condition, undergo the treatment confidently. Find More Patient Testimonial Videos: Patient Speak Like and […]

Read More
Categories Multiple Myeloma

GVHD Prophylaxis: Similar Outcomes With PTCy and ATG

GVHD Prophylaxis: Similar Outcomes With PTCy and ATG A newer regimen was no more effective than an older regimen when both were compared for graft versus host disease (GVHD) prophylaxis in patients who underwent reduced-intensity conditioning followed by a hematopoietic stem cell transplant (HSCT) from a 10/10 HLA-matched related or unrelated donor. These results come […]

Read More
Categories Multiple Myeloma

Multiple Myeloma Treatment Paradigm Improved Markedly In Recent Years

Multiple Myeloma Treatment Paradigm Improved Markedly In Recent Years Kenneth C. Anderson, MD, Kraft Family Professor of Medicine at Harvard Medical School and program director of Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber Cancer Institute, discusses how he has seen the treatment paradigm transform over the last decade in […]

Read More
Categories Multiple Myeloma

Zacks: Analysts Expect Fate Therapeutics, Inc. (NASDAQ:FATE) Will Post Quarterly Sales of $7.07 …

Zacks: Analysts Expect Fate Therapeutics, Inc. (NASDAQ:FATE) Will Post Quarterly Sales of $7.07 … Wall Street analysts expect Fate Therapeutics, Inc. (NASDAQ:FATE) to report $7.07 million in sales for the current quarter, according to Zacks Investment Research. Eight analysts have issued estimates for Fate Therapeutics’ earnings. The lowest sales estimate is $5.00 million and the […]

Read More
Categories Multiple Myeloma

Bromodomain Testis Specific Protein Market 2021 Complete Data Analysis

Bromodomain Testis Specific Protein Market 2021 Complete Data Analysis Global Bromodomain Testis Specific Protein Market Overview: Global Bromodomain Testis Specific Protein Market presents insights on the current and future industry trends, enabling the readers to identify the products and services, hence driving the revenue growth and profitability. The research report provides a detailed analysis of […]

Read More
Categories Multiple Myeloma

NEWS FEATURE | Ultimate pain killer: doctor with cancer fights to the death for assisted suicide

NEWS FEATURE | Ultimate pain killer: doctor with cancer fights to the death for assisted suicide Palliative care specialist uses her years caring for terminal patients and her own experience of cancer to strengthen her case 15 March 2021 – 19:54 On February 3 2017, palliative care specialist Dr Sue Walter was driving in Joburg […]

Read More
Categories Multiple Myeloma

Martin Compares Triplet and Quadruplet Therapies in Newly Diagnosed Multiple Myeloma

Martin Compares Triplet and Quadruplet Therapies in Newly Diagnosed Multiple Myeloma During a virtual Targeted Oncology Case-Based Rountable, Thomas G. Martin, MD, a clinical professor of Medicine, associate director, Myeloma Program ,and coleader, Hematopoietic Malignancies Program, at the Helen Diller Family Comprehensive Cancer Center of University of California, San Francisco, discussed triplet and quadruplet combination […]

Read More
Categories Multiple Myeloma

Zacks: Brokerages Expect BeiGene, Ltd. (NASDAQ:BGNE) Will Post Earnings of -$3.47 Per Share

Zacks: Brokerages Expect BeiGene, Ltd. (NASDAQ:BGNE) Will Post Earnings of -$3.47 Per Share Analysts predict that BeiGene, Ltd. (NASDAQ:BGNE) will announce earnings per share (EPS) of ($3.47) for the current quarter, Zacks reports. Two analysts have made estimates for BeiGene’s earnings. The lowest EPS estimate is ($4.77) and the highest is ($1.04). BeiGene reported earnings […]

Read More